NEW YORK (TheStreet) -- After the market's 10% selloff and subsequent rally, there are still a few buying opportunities left, said Stephen Weiss, founder and managing partner of Short Hills Capital Partners LLC.
On Wednesday's CNBC's "Fast Money Halftime Report he said he specifically likes airline stocks because of falling fuel costs, as well as portfolio protection via a long position in the CBOE Volatility Index I:VIX .
Investors should wait for a pullback in airline stocks, Pete Najarian, co-founder of optionmonster.com and trademonster.com, argued, with the exception of American Airlines (AAL) - Get Report which is a buy near current levels. Chip stocks likes Intel (INTC) - Get Report are also attractive near current levels.
Not just Intel, but Micron (MU) - Get Report too. Mike Murphy, founder of Rosecliff Capital, reasoned that the stock is cheap and has the potential to do a large share repurchase. He also likes International Paper (IP) - Get Report .
On Tuesday hedge fund manager Carl Icahn told the panel there is a "bubble" forming in high yield fixed-income.
On Wednesday Brown agreed with Icahn, adding that the iShares High Yield Corporate Bond ETF (HYG) - Get Report is getting "too crowded" and has more downside than many investors realize. Instead, he prefers the iShares U.S. Preferred Stock ETF (PFF) - Get Report , which has less risky assets and a higher yield.
Investors are failing to realize the amount of risk they're taking when they buy high yield fixed-income, Weiss added, when they could take far less risk in safer assets while only sacrificing a little yield.
If investors don't want to be in fixed-income they can buy quality stocks with safe dividend payouts, Najarian said.
Yahoo! (YHOO) was the first stock on the show's "Trader's Blitz" segment, following a beat on revenue and earnings. Brown said investors should take profits and look to buy below $40. Weiss and Murphy agreed.
Broadcom (BRCM) reported strong revenue growth, Najarian said. The stock is still cheap, based on valuation, but investors should wait for a pullback before getting long.
Weiss said Dow Chemical (DOW) - Get Report is attractive after its latest earnings results, while Murphy advised investors to wait for a larger pullback in Boeing (BA) - Get Report before getting long.
Top-ranked biotech analyst Yaron Werber of Citigroup said his top large-cap pick is Gilead Sciences (GILD) - Get Report , which should see strong demand for its hepatitis C drug. Medivation (MDVN) is his top small-cap pick in biotech. He also likes Amgen (AMGN) - Get Report on the long side but said the company needs to improve margins.
"I love Gilead," Weiss said, who also bought a small long position in Amgen. Brown said investors should avoid Biogen Idec (BIIB) - Get Report , which is selling off following what appeared to be a good earnings report.
When asked whether to buy or sell shares of Coca-Cola (KO) - Get Report , Najarian replied, "hold." The company's partnership with Monster Beverage (MNST) - Get Report will benefit both companies but will take a while to play out.
However, Murphy and Brown were both sellers of the stock, with Brown saying Coca-Cola's core business is in decline and will likely remain that way going forward. Shares of Coca-Cola are overvalued at 20 times earnings, Weiss said, given that growth is stagnant and management fails to execute.
-- Written by Bret Kenwell